Obesity
Opinion
Weight bias affects views of kids’ obesity recommendations
For childhood obesity, we thankfully now have a number of effective treatment options that we can offer, and it’s only our societal weight bias...
From the Journals
Size of meals, not timing, linked to weight loss
More small meals were associated with weight loss, regardless of time between them, in a prospective cohort study.
From the Journals
Emotional eating tied to risk of diastolic dysfunction
Cardiovascular disease prevention should include emotional regulation education, researchers suggest.
From the Journals
Diet packed with fast food found hard on the liver
“Striking” elevations in steatosis were evident among persons with obesity and diabetes who consumed fast food, in comparison with their...
From the Journals
Does obesity blunt effects of vitamin D supplementation?
‘There seems to be something different happening with vitamin D metabolism at higher body weights,’ said the author of a new paper.
From the Journals
‘Clinical paradox’? Bariatric surgery may protect from GI cancers
The study marks “an important step toward improving the understanding of potential lifetime risks of bariatric surgery and overall major health...
From the Journals
Obesity impacts peripheral airway reactivity, asthma
Overall, most obese individuals with and without asthma showed significant changes in peripheral airway resistance.
From the Journals
New guidelines on peds obesity call for aggressive treatment
The authors of the guidelines encourage primary care doctors to collaborate with other medical professionals to treat the comorbidities often...
News
Earlier colorectal cancer screening appears cost-effective in overweight, obese patients
Starting colonoscopy at age 45 seems to be cost-effective for both men and women.
Feature
Best diets in 2023: Mediterranean diet wins again
U.S. News & World Report’s latest annual rankings of the best diet plans has been released.
News
FDA approves Wegovy (semaglutide) for obesity in teens 12 and up
FDA approves semaglutide 2.4mg (Wegovy), a once-weekly subcutaneous injection, for treating obesity in adolescents aged 12 years and older.